PCWA
ONCO icon

Pacific Capital Wealth Advisors’s Onconetix ONCO Stock Holding History

Pacific Capital Wealth Advisors’s Portfolio ONCO Stock Details ONCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-260
Closed -$40.4K – 80
2025
Q3 		$40.4K Buy
+260
New +$43.8K 0.01% 79

Other funds holding ONCO

DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Pacific Capital Wealth Advisors's ONCO Position: Q4 2025 in Review

Pacific Capital Wealth Advisors sold out of Onconetix (ONCO) in Q4 2025, closing a stake of 260 shares — an estimated $40.4K sold.

Pacific Capital Wealth Advisors first reported a position in ONCO in Q3 2025 and held it in 1 quarter. The position peaked at $40.4K in Q3 2025. 5 funds tracked by Wall St. Rank hold ONCO as of Q4 2025.

  • Pacific Capital Wealth Advisors reported no remaining Onconetix position as of Q4 2025 after selling out during the quarter.
  • Pacific Capital Wealth Advisors sold 260 Onconetix shares in Q4 2025, an estimated $40.4K.
  • Pacific Capital Wealth Advisors first reported a position in Onconetix in Q3 2025 and held it in 1 quarter.
  • Pacific Capital Wealth Advisors's Onconetix position peaked at $40.4K in Q3 2025.
  • 5 funds tracked by Wall St. Rank held Onconetix as of Q4 2025.

Based on Pacific Capital Wealth Advisors's 13F filing for Q4 2025, filed 26 Jan 2026.